Brain biopsy is the removal of a small piece of brain tissue for the diagnosis of abnormalities of the brain. It is used to diagnose , infection, inflammation, and other brain disorders. By examining the tissue sample under a microscope, the biopsy sample provides information about the appropriate diagnosis and treatment.
If the person has a brain tumor, biopsy is 95% sensitive. The procedure can also be valuable in people who are Immunodeficiency and who have evidence of brain lesions that could be caused by opportunistic infections. In other groups, particularly those with unexplained neurological disease, a diagnosis is reached by performing a biopsy in half the cases where it is done, and it has helpful practical effect in 30% of people. If primary angiitis of the central nervous system (PACNS) is suspected, brain biopsy is most likely to positively influence the treatment plan.
When an abnormality of the brain is suspected, stereotactic (probing in three dimensions) brain needle biopsy is performed and guided precisely by a computer system to avoid serious complications. A small hole is drilled into the skull, and a needle is inserted into the brain tissue guided by computer-assisted imaging techniques (CT or MRI scans). Historically, the patient's head was held in a rigid frame to direct the probe into the brain; however, since the early 1990s, it has been possible to perform these biopsies without the frame. Since the frame was attached to the skull with screws, this advancement is less invasive and better tolerated by the patient. The doctor (pathologist) prepares the sample for analysis and studies it further under a microscope.
If brain biopsy is performed for a possible tumor (which contain more blood vessels), the risk of death is 1% and a risk of complications 12%. For unexplained neurological disease, there is no risk of death and a complication rate of 9%; complications were more common in PACNS.
Interpretation
See also
|
|